Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 116, Issue 3, Pages 652-662Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI24751
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA083133] Funding Source: Medline
Ask authors/readers for more resources
CD34(+) bone marrow-derived progenitor cells contribute to tissue repair by differentiating into endothelial cells, vascular smooth muscle cells, hematopoietic cells, and possibly other cell types. However, the mechanisms by which circulating progenitor cells home to remodeling tissues remain unclear. Here we show that integrin alpha(4)beta(1) (VLA-4) promotes the homing of circulating progenitor cells to the alpha(4)beta(1) ligands VCAM and cellular fibronectin, which are expressed on actively remodeling neovasculature. Progenitor cells, which express integrin alpha(4)beta(1), homed to sites of active tumor neovascularization but not to normal nonimmune tissues. Antagonists of integrin alpha(4)beta(1), but not other integrins, blocked the adhesion of these cells to endothelia in vitro and in vivo as well as their homing to neovasculature and outgrowth into differentiated cell types. These studies describe an adhesion event that facilitates the homing of progenitor cells to the neovasculature.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available